Nicholas F. Brown
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial.
Journal: Neuro-oncology advances
Published: August 13, 2025
Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: October 24, 2023
Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment.
Journal: Cancers
Published: October 17, 2023
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.
Journal: British journal of cancer
Published: October 28, 2019
Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: October 07, 2019
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
Journal: Theranostics
Published: July 24, 2019
Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment.
Journal: Cancers
Published: July 19, 2019
CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2019
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 31, 2018
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098.
Journal: Neuro-oncology
Published: May 23, 2018
Last Updated: 09/26/2026